Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway

Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway

Yuehong Cui,1,* Qian Li,1,* Hong Li,1 Yan Wang,1 Hongshan Wang,2 Weidong Chen,2 Shangmin Zhang,3 Jian Cao,3 Tianshu Liu1 1Medical Oncology Department, 2General Surgery Department, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China; 3Pathology Department, Yale Schoo...

Full description

Bibliographic Details
Main Authors: Cui Y, Li Q, Li H, Wang Y, Wang H, Chen W, Zhang S, Cao J, Liu T
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:OncoTargets and Therapy
Subjects:
Asparaginyl endopeptidase
EGFR signaling pathway
drug resistance
gastric carcinoma
Online Access:https://www.dovepress.com/asparaginyl-endopeptidase-improves-the-resistance-of-microtubule-targe-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/asparaginyl-endopeptidase-improves-the-resistance-of-microtubule-targe-peer-reviewed-article-OTT

Similar Items